As one of the main causes of dementia, Alzheimer's disease (AD) is characterized by the accumulation of amyloid β (Aβ) and hyperphosphorylated tau in the brain as major neuropathological hallmarks ([@bhz020C65]). This leads to neuronal dysfunction and ultimately cell death, which is clinically accompanied by progressive cognitive decline such as memory impairment and executive dysfunction ([@bhz020C12]; [@bhz020C7]).

Since the neuropathological changes occur many decades before the manifestation of clinical symptoms ([@bhz020C67]), early detection may offer an essential aspect in disease prevention. Biomarkers obtained from cerebrospinal fluid (CSF) and positron emission tomography (PET) imaging are often routinely used when classifying subjects as amyloid positive or negative ([@bhz020C6]; [@bhz020C55]). Although CSF markers detect amyloid abnormalities slightly earlier than PET ([@bhz020C51]), CSF Aβ seems to plateau earlier during the nondementia stage of AD where PET amyloid accumulation still increases ([@bhz020C72]; [@bhz020C52]), possibly because they represent different aspects of the pathology ([@bhz020C44]; [@bhz020C51]). Furthermore, whole brain imaging has the advantage of regional specificity, enabling PET imaging to grade the amount of amyloid burden at a more detailed level than global CSF markers ([@bhz020C54]).

In addition to Aβ PET, also other imaging modalities have provided great insight into the disease progress of AD. Previous work focusing on AD patients has shown that brain metabolism ([@bhz020C49]), neuronal activation ([@bhz020C22]), resting-state functional connectivity ([@bhz020C47]), and brain structure ([@bhz020C34]) deteriorate across the AD spectrum. To further investigate brain alterations in prodromal stages of AD, various studies have been carried out in mild cognitive impairment and healthy elderly subjects with mixed results. Interestingly, several studies examining nondemented populations have observed associations of Aβ accumulation with increases in brain function and connectivity ([@bhz020C66]; [@bhz020C46]; [@bhz020C43]), which is often interpreted as a potential compensatory mechanism. It is important to note that the vast majority of these studies included subjects already exhibiting increased and widespread neocortical Aβ pathology. Given that deposition of Aβ fibrils is considered to represent one of the earliest changes in AD ([@bhz020C65]), which is believed to begin at least 1--2 decades before dementia onset ([@bhz020C3]; [@bhz020C11]; [@bhz020C32]), it is crucial to consider amyloid status when targeting the early onset stage. Recent investigations of nondemented individuals have identified the brain regions that are most prone to exhibit increased Aβ accumulation in the earliest stages of AD, and these regions mainly include certain parts of the default mode (DM) network ([@bhz020C73]; [@bhz020C23]; [@bhz020C53]). However, further studies are needed to determine whether this very early accumulation of Aβ fibrils affects brain connectivity, structure and function.

To this end, we evaluated the associations of amyloid (\[^18^F\]Flutemetamol) PET uptake in the brain regions with earliest Aβ deposition with functional connectivity, gray matter volume, white matter diffusivity and cognitive performance in nondemented individuals with an overall negative amyloid PET scan (i.e., they exhibited both a normal neocortical composite SUVR and normal visual read). Considering that functional connectivity exhibits nonstationary characteristics over time ([@bhz020C29]; [@bhz020C14]), this was further split into different dynamic states. Dynamic functional connectivity has been demonstrated to represent behaviorally relevant information ([@bhz020C33]) and to differ between various mental disorders ([@bhz020C42]; [@bhz020C76]), but its relation to amyloid pathology has not yet been assessed.

Methods {#bhz020s2}
=======

Subjects {#bhz020s3}
--------

In the present study we included 133 nondemented elderly subjects, consisting of 85 healthy subjects and 48 with subjective cognitive decline (SCD) from the Swedish BioFINDER study (<http://biofinder.se>). All cases were without clinically relevant amyloid deposition (i.e., all were PET negative subjects, see definition below). See Table [1](#bhz020TB1){ref-type="table"} for demographic details. Details about study design, methods, and specific inclusion/exclusion criteria of the BioFINDER study have previously been described ([@bhz020C31], [@bhz020C30]; [@bhz020C53]). In the present study the following cognitive tests were included: Mini Mental State Examination (MMSE) as a measure of global cognition, the 10-word delayed recall part of the Alzheimer's Disease Assessment Scale, cognitive subscale (ADAS-cog) as a measure of memory performance, and A Quick Test of cognitive speed (AQT), color-form version as a measure of cognitive speed and attention. All participants provided written informed consent after detailed explanation of the study protocol. The study was approved by the Ethical Review Board of Lund University and all procedures were performed according to the Declaration of Helsinki. Table 1Demographic details (mean ± sd). The sample comprised healthy controls (HC) and those with subjective cognitive decline (SCD)). All participants had an MMSE score ≥ 25 and did not exhibit clinically relevant amyloid deposition (i.e., PET negative). \[^18^F\] Flutemetamol SUVR, standard uptake value ratios of brain regions prone to early amyloid uptake (Fig. [1](#bhz020F1){ref-type="fig"}); MMSE, mini mental state examination score. Delayed recall, 10-word delayed recall part of the Alzheimer's disease assessment scale (number of errors out of 10); AQT, a quick test of cognitive speed color-form version (reaction time in seconds); APOE ε4, carriers of 1 or 2 alleles; History, family history of dementia in first degree relativesHCSCDAll*n*8548133Sex (m/f)32/5320/2852/81Age (years)73.7 ± 4.268.9 ± 5.572.0 ± 5.2\[^18^F\] Flutemetamol SUVR0.58 ± 0.060.61 ± 0.060.59 ± 0.06MMSE29.0 ± 1.028.9 ± 1.429.0 ± 1.2Delayed recall (errors)1.8 ± 1.92.7 ± 2.02.1 ± 2.0AQT (s)66.5 ± 12.672.3 ± 24.968.6 ± 18.1Education (years)11.8 ± 3.113.8 ± 3.112.5 ± 3.2APOE e4 (%)20.029.223.3History (%)30.647.936.8

Positron Emission Tomography {#bhz020s4}
----------------------------

To assess Aβ accumulation in the brain, PET imaging was carried out as described previously ([@bhz020C54], [@bhz020C53]). Briefly, all subjects underwent a PET examination with \[^18^F\]Flutemetamol on a Philips Gemini TF 16 scanner (Philips Healthcare). The radioligand represents an ^18^F-labeled analog to \[^11^C\]PiB, where both bind specifically to Aβ ([@bhz020C71]; [@bhz020C28]). The mean injected dose was 185 MBq and PET images were acquired 90--110 min postinjection (5 min per frame), followed by a CT scan for attenuation correction. Image processing included movement correction, averaging across time and spatial normalization to MNI-space ([@bhz020C53]). Standard uptake value ratio (SUVR) images were computed using a combined reference region (whole cerebellum, pons/brainstem, eroded subcortical white matter) ([@bhz020C39]). Correction for partial volume effects was carried out with the geometric transfer matrix method ([@bhz020C59]) by calculating and inverting the transfer matrix between tissue regions extracted from FreeSurfer segmentation. This correction step ensures that our results are not driven by potential differences in gray matter volume. All subjects showed normal Aβ accumulation, that is, they were PET negative (PET−) according to a recently described classification ([@bhz020C53]). In short, SUVR values of a neocortical composite region (frontal, lateral parietal, lateral temporal, anterior cingulate, posterior cingulate, precuneus) ([@bhz020C45]) were required to be \<0.759 as defined with a mixture modeling analysis in a larger sample of the BioFINDER study (*n* = 406). SUVR images were then masked by a conservative gray matter template ([@bhz020C75]). Furthermore, all PET images were visually inspected by 3 experienced external physicians (at MNI, New Haven, USA), who independently classified all PET images as positive or negative. The physicians were blind to clinical data and the scans rated here were part of a larger data collection which included many positive cases as well. The final classification was obtained by majority rule, where at least 2 of the 3 physicians rated a subject as negative.

To evaluate associations between Aβ accumulation and MR imaging parameters, we extracted the average \[^18^F\]Flutemetamol SUVR from brain regions that are most prone to the earliest accumulation of Aβ (Fig. 1a in [@bhz020C53]). The regions comprised the posterior cingulate cortex and precuneus, the subgenual part of the anterior cingulate cortex and to a lesser extent bilaterally the angular gyrus, posterior middle temporal gyrus and middle frontal gyrus (Fig. [1](#bhz020F1){ref-type="fig"}, *P* \< 0.05 FWE-corrected voxel level, which is more stringent than previously published ([@bhz020C53]) to focus on regions with strongest changes). The regions are similar to those observed as the most affected early Aβ-positive regions in autosomal dominant AD ([@bhz020C69]). Furthermore, the regions correspond to those classified as early (stage 2) Aβ progression ([@bhz020C24]) and show substantial overlap with another study assessing early stages of Aβ deposition ([@bhz020C73]). Since these brain regions largely comprise the DM network we also extracted SUVR values explicitly from the DM as defined in a low (7 networks) and high resolution (17 networks) parcellation of the brain ([@bhz020C75]).

![Brain regions which are most prone to earliest amyloid accumulation as identified in a recent analysis of the ADNI cohort (*P* \< 0.05 FWE-corrected voxel level) ([@bhz020C53]). The average \[^18^F\]Flutemetamol SUVR across these regions was extracted for each subject and used for further analysis.](bhz020f01){#bhz020F1}

Magnetic Resonance Imaging {#bhz020s5}
--------------------------

Magnetic resonance imaging (MRI) was carried out with a 3 T Siemens Tim Trio scanner (Siemens Medical Solutions, Erlangen, Germany). This included acquisition of a T1-weighted structural MRI (magnetization prepared rapid gradient echo sequence, TE/TR = 3.37/1950 ms, 1 × 1 × 1.2 mm^3^), diffusion weighted images (single-shot echo planar imaging sequence, TE/TR = 86/8200 ms, 64 diffusion encoding directions at *b* = 1000 s/mm^2^ and one image at *b* = 0 s/mm^2^, 2 × 2 × 2 mm^3^) as well as 6 min functional MRI at resting-state with eyes closed (gradient-recalled echo planar imaging, TE/TR = 30/2000 ms, 3 × 3 × 3 mm^3^).

Voxel-Based Morphometry {#bhz020s6}
-----------------------

T1-weighted images were segmented and spatially normalized to MNI-space with the CAT12 toolbox (<http://www.neuro.uni-jena.de/cat/>) for SPM12 (<http://www.fil.ion.ucl.ac.uk/spm/>) using default parameters. Gray matter segments were converted to gray matter volume by multiplication with the Jacobian determinants to adjust for effects of nonlinear deformations. The final images were smoothed with an 8 mm Gaussian kernel.

Diffusion Tensor Imaging {#bhz020s7}
------------------------

Diffusion weighted images were processed with FSL (<https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/>), which included correction for eddy currents and movement, brain extraction and estimation of the tensor. This resulted in images representing mean diffusivity and fractional anisotropy (FA). Spatial normalization was carried out using tract based spatial statistics (TBSS) ([@bhz020C63]) with default parameters. Here, the individual FA images were nonlinearly registered to MNI-space and a white matter skeleton was created where FA images were mapped to. Images of mean diffusivity were normalized with the transformations obtained from the FA processing step.

Static Functional Connectivity {#bhz020s8}
------------------------------

fMRI data processing was carried out as described recently ([@bhz020C53]) and included processing with FSL, AFNI (<https://afni.nimh.nih.gov/>), ANTS (<https://sourceforge.net/projects/advants/>), and Matlab (The Mathworks, Natick, MA). Functional images were corrected for slice timing differences and head motion. Confounding signals were removed by linear regression against signals from CSF and white matter, 6 components of physiological noise ([@bhz020C4]) and 24 motion parameters ([@bhz020C21]). Finally, a band-pass filter was applied (0.01 \< *f*\< 0.1 Hz). Processed images were then transformed to MNI-space. Since subject motion is an essential issue in resting-state fMRI analyses, all subjects exceeding a framewise displacement of 0.6 mm on average and 3 mm at maximum were removed ([@bhz020C57]). Another precaution was included in this elderly population by summing up the voxel-to-voxel BOLD signal correlations across the entire brain. Outliers in this metric most likely reflect motion-related global signal confounds and where thus removed ([@bhz020C27]). The 133 subjects stated above already represent the final sample after applying these exclusion criteria. Finally, fMRI frames were censored if they constituted outliers in the total signal frame-to-frame variation (75% plus 1.5 times interquartile range).

Static functional connectivity matrices were computed by cross-correlation of the entire BOLD signal time courses between each region of interest pair. Brain regions were defined using a publicly available atlas of 840 regions based on resting-state fMRI data ([@bhz020C15]). This represents a detailed parcellation of the human brain close to a voxel-wise analysis but with the advantage of processing a computationally feasible amount of data. The resulting correlation values were then *z*-transformed with Fisher's *r*-to-*z* transformation.

Dynamic Functional Connectivity {#bhz020s9}
-------------------------------

Data processing was identical as for the static analysis until the calculation of connectivity matrices. Dynamic functional connectivity was computed for the symmetric matrix defined by the 840 × 840 region pairs using an exponentially tapered sliding window approach ([@bhz020C78]). The weighting step assigns highest weights to the most recent events and the exponential smoothing avoids sudden changes in functional connectivity, making it less susceptible to outlier values. The time window for each dynamic connectivity matrix was *N* = 60 s ([@bhz020C78]) and the weight vector was defined as an exponential function ([@bhz020C58]): $$w_{t} = w_{0} \ast e^{(t - N)/\theta}$$with *t* = 1...*N* and *w*~0~ being $$w_{0} = (1 - e^{- 1/\theta})/(1 - e^{- N/\theta})$$where the exponent $\theta$ was set to 1/3 of the window length ([@bhz020C78]). Weighted Pearson's correlation coefficients were then computed from weighted means, standard deviation, and covariances, followed by *z*-transformation. Dynamic functional connectivity matrices across time were computed by consecutively shifting the time window by 1 TR. The values for the exponent ([@bhz020C58]) and window length ([@bhz020C29]; [@bhz020C1]) were based on previous reports ([@bhz020C78]) as it was demonstrated that these represent reasonable choices.

Identification of Dynamic Connectivity States {#bhz020s10}
---------------------------------------------

Dynamic functional connectivity is characterized by repeatedly occurring states ([@bhz020C78]). To identify these different connectivity states, *k*-means clustering was carried out with Matlab using dynamic functional connectivity matrices of all subjects as features and 1-correlation as similarity metric ([@bhz020C29]; [@bhz020C1]). For the clustering, connectivity matrices were thresholded at a network density of 20% (i.e., only keeping the strongest 20% of connections) to avoid influence of spurious correlations ([@bhz020C78]). Clustering was repeated for a variable number of clusters (*k* = 2--10 and 10--20 with steps = 1 and 2, respectively). The optimal solution across all clustering results was determined by the elbow criterion ([@bhz020C1]), where the within sum of squares did not show a marked improvement anymore for a higher number of clusters. For each subject multiple occurrences of a certain state were averaged for further statistical evaluation.

Due to previous concerns of clustering sliding window correlations ([@bhz020C37]), the cluster centroids obtained from dynamic functional connectivity were compared with centroids of random connectivity matrices. For computational reasons this procedure was carried out with a randomly selected subset of the total sample (*n* = 43), for *k* = 6 clusters and 3 repeats with random initial centroids. Since the similarity metric was 1-correlation, we also used the correlation to compute the within- and between-cluster distance.

Furthermore, sliding window correlations were also computed with a window of *N* = 46 s as this represents the middle of previously proposed window lengths of 30--60 s ([@bhz020C62]; [@bhz020C29]). The resulting states were then compared with those obtained with the *N* = 60 s window.

Statistical Analysis {#bhz020s11}
--------------------

Associations between \[^18^F\]Flutemetamol SUVR, MR imaging parameters, cognitive test scores (MMSE, AQT, ADAS-cog), years of education, and first degree family history of dementia were calculated with linear regression analysis. For whole-brain static and dynamic functional connectivity the Network Based Statistics (NBS) toolbox ([@bhz020C77]) was used. To control for false positives within whole-brain connectivity matrices of 840 regions, the initial connection threshold was set to *P* \< 0.0001 uncorrected, followed by a network threshold of *P* \< 0.05 FWE corrected. Hence, all *P*-values provided in the results are FWE corrected. Statistical testing was done with 5000 random permutations and intensity weighting (i.e., weighting by connection strength). In other words, the total intensity (i.e., the sum of *t*-values of suprathreshold links) of an observed network component was compared with a permutation generated null distribution of component intensities, thereby assigning an FWE-corrected *P*-value to the observed network component. To calculate *r*-values for significant associations, the functional connections of the significant network components were weighted by *t*-values, averaged for each subject and correlated with the variable of interest. The extracted network components which showed a significant association with \[^18^F\]Flutemetamol SUVR, where also correlated with cognitive test scores. SPM12 and FSL were used to compute whole-brain regressions with gray matter volume (*P* \< 0.05 FWE-corrected voxel level, cluster extent \>10 voxels) and white matter diffusion parameters (500 random permutations, *P* \< 0.05 FWE-corrected with threshold free cluster enhancement), respectively. In order to obtain more generalizable results of an elderly population independent of potential confounders and risk factors, all statistical analyses were corrected for sex, age, clinical diagnosis (healthy, SCD), and APOE ε4 status (noncarriers vs. carriers of 1 or 2 alleles). Visualization of connectograms and brain networks was carried out with Circos ([@bhz020C38]) and BrainNet Viewer ([@bhz020C74]), respectively. For the connectograms each element of a 840 × 840 connectivity matrix was allocated to 1 of 7 cortical resting-state networks (DA, dorsal attention; DM, default mode; FP, frontoparietal; FT, frontotemporal; SM, somatomotor; VA, ventral attention; VI, visual) ([@bhz020C75]), the basal ganglia (BG), the amygdala/hippocampus (HI), or the cerebellum (CER) from the Harvard--Oxford atlas as included in FSL.

Results {#bhz020s12}
=======

We have recently identified the cortical regions most prone to accumulate Aβ fibrils during the earliest stages of AD ([@bhz020C53]) (Fig. [1](#bhz020F1){ref-type="fig"}). In the current study the average \[^18^F\]Flutemetamol SUVR was extracted from these regions in 133 nondemented and Aβ PET negative cases from the BioFINDER cohort.

Static Functional Connectivity {#bhz020s13}
------------------------------

The \[^18^F\]Flutemetamol uptake in the early Aβ regions did not show an association with static functional connectivity. This was also not the case when extracting \[^18^F\]Flutemetamol SUVR from the high or low resolution DM defined by [@bhz020C75] or when using SUVRs from the neocortical composite score ([@bhz020C46]).

Dynamic Functional Connectivity {#bhz020s14}
-------------------------------

*K*-means clustering identified 6 dynamic connectivity states as best solution, which is similar to previous studies ([@bhz020C1]; [@bhz020C76]). All states exhibited a common backbone of links (calculated as the average across all subjects and states), which was characterized by strong within network connections as well as default mode, dorsal attention, ventral attention, and somatomotor connections with other networks (Fig. [2](#bhz020F3){ref-type="fig"}). The common backbone almost perfectly reflected the average static functional connectivity pattern with *r* = 0.97 between the 840 × 840 matrices (both thresholded at a network density of 20%, Fig. [2](#bhz020F3){ref-type="fig"}). Furthermore, each of the 6 states exhibited connections, which were specific to itself (i.e., \>2 SD stronger than average). State 1 showed additional links of the default mode, visual and cerebellar networks. State 2 exhibited frontoparietal connections and default mode links with other networks. In state 3, connections of the ventral attention network were dominant. State 4 showed strong somatomotor links. States 5 and 6 were mostly characterized by default mode connections.

![Associations between \[^18^F\]Flutemetamol SUVR extracted from regions shown in Fig. [1](#bhz020F1){ref-type="fig"} and dynamic resting-state functional connectivity, adjusted for the covariates sex, age, APOE ε4 status and presence of SCD (*P* \< 0.05 FWE corrected). Functional connectivity further showed a positive correlation with MMSE scores. Line thickness in connectogram is proportional to association strength (*t*-values). The *r*-values denote Pearson correlation coefficients after correction for covariates using regression. After correction the original mean values were added to the residuals to approximate the raw values, thus calculated values are relative and may exceed the maximum of the MMSE. BG, basal ganglia; CER, cerebellum; DA, dorsal attention; DM, default mode (red); FP, frontoparietal (green); FT, frontotemporal; HI, amygdala-hippocampus; SM: somatomotor (blue); VA, ventral attention; VI, visual.](bhz020f02){#bhz020F2}

Detailed evaluation of sliding window correlations showed good similarity of cluster centroids within functional connectivity data (*r* = 0.82 ± 0.05), which was markedly different to random matrices (*r* = 0.002 ± 0.0004). This indicates that clustering obtained from sliding window correlations of dynamic functional connectivity data is clearly different to that of random data ([@bhz020C37]). Changing the sliding window to *N* = 45 s also showed high reproducibility of the functional connectivity states (*r* = 0.97 ± 0.02).

Of the 6 dynamic states, only functional connectivity of state 1 was positively associated with \[^18^F\]Flutemetamol SUVR in the early Aβ region (*r* = 0.77, Fig. [3](#bhz020F2){ref-type="fig"}). The correlation featured strong default mode connections with the ventral attention and somatomotor networks as well as between the ventral attention and visual networks and comprised 122 regions (out of 840) and 145 edges. Additionally correcting for individual gray matter volume of the early Aβ region (*r* = 0.77), global white matter hyperintensity volume (*r* = 0.77), Fazekas score (*r* = 0.76) or Wahlund score (*r* = 0.76) did not affect this relationship. The connections, which were associated with SUVR, were also related to a better MMSE score (*r* = 0.21, Fig. [3](#bhz020F2){ref-type="fig"}). Extracting SUVR from the DM ([@bhz020C75]) showed a significant association with functional connectivity of state 1 for the low (*r* = 0.70, 75 regions, 87 edges) and high resolution parcellations (*r* = 0.71, 71 regions, 82 edges). No significant correlation was observed for SUVRs from the neocortical composite score. Further exploratory whole-brain correlations with cognitive test scores were found for state 3 (*r* = 0.51, VI--SM connections) and 6 with higher MMSE scores (*r* = 0.50, CER--VA, and CER--SM connections) and for state 3 with ADAS error rate (*r* = −0.72, FT--VA, and FT--SM connections).

![Dynamic functional connectivity states and number of subjects exhibiting each state (total sample *n* = 133). Average static (and dynamic) connections across all subjects (and states) showed strong overlap (*r* = 0.97). For each of the 6 states only those connections are shown, which are stronger than the common ones (i.e., \>2 standard deviations stronger than the average). Line thickness is proportional to connectivity strength (*z*-score). Line thickness of average connections is downscaled by 200 for visualization and only the strongest 20% of connections are shown. See Figure [3](#bhz020F2){ref-type="fig"} for abbreviations and color code.](bhz020f03){#bhz020F3}

Structural MRI {#bhz020s15}
--------------

No significant associations were found between \[^18^F\]Flutemetamol uptake in the early Aβ region and any regional gray matter volumes or any of the regional white matter diffusion parameters (mean diffusivity, FA).

Discussion {#bhz020s16}
==========

Proceeding from brain regions previously identified as the most susceptible to the earliest amyloid deposition ([@bhz020C53]), we here demonstrated robust positive associations of \[^18^F\]Flutemetamol amyloid uptake in these regions with resting-state fMRI functional connectivity in a large sample of nondemented elderly subjects of the BioFINDER study. Importantly, the sample comprised only PET negative subjects, that is, those without clinically relevant global amyloid deposition and a negative visual read, and the observed associations were independent of confounding factors such as age, sex, APOE ε4 status, presence of SCD, and structural alterations. These findings suggest that the very earliest accumulation of Aβ fibrils are biologically relevant and indeed affect brain function.

Interestingly, only dynamic but not static functional connectivity was associated with Aβ uptake. This indicates that static functional connectivity analysis exhibits decreased sensitivity when capturing the association in the earliest stages of Aβ accumulation. Hence, separating the different dynamic functional states may offer increased ability to detect alterations in brain connectivity as compared with the commonly used approach of temporally static connectivity, since the latter may simply represent an average of the different dynamic states ([@bhz020C35]). This is confirmed by the remarkable match between static functional connectivity and average dynamic connectivity observed here (*r* = 0.97). Accordingly, dynamic functional connectivity has been shown to outperform static one with respect to patient classification in post-traumatic stress disorder ([@bhz020C35]).

Most studies of functional connectivity in AD focused on the DM, due to the large overlap with Aβ accumulation ([@bhz020C13]). A recent study identified the posterior DM as initially failing region and its connectivity with other hubs being associated with Aβ accumulation ([@bhz020C36]). However, the earliest deposition of Aβ also comprises other networks such as the frontoparietal, dorsal and ventral attention. ([@bhz020C53]). In line with this, the neocortical composite score did not yield significant correlations and extraction of \[^18^F\]Flutemetamol SUVR from the entire DM resulted in a substantially smaller network, which emphasizes the relevance of regional specificity ([@bhz020C52]). The overlap of early Aβ deposition and the DM is characterized in further detail by the current work. We indeed confirm that mainly DM connections are involved, but it seems that links to other networks rather than within-network connections are predominantly affected by the earliest Aβ fibril burden ([@bhz020C10]; [@bhz020C18]). This indicates that global network coordination appears to be more important than local circuit functioning in the pathophysiology of AD.

Similar to the topology of earliest Aβ deposition ([@bhz020C53]), the positively associated functional connections were also characterized by links of the DM with the ventral attention network. These findings are in line with previously reported increases of neuronal activation ([@bhz020C19]) and functional connectivity ([@bhz020C46]; [@bhz020C18]) in healthy elderly subjects with increased amyloid binding. More importantly, the regions and networks involved in the earliest stages also match those, that are affected as the disease progresses eventually into Alzheimer's dementia ([@bhz020C9]; [@bhz020C18]), despite the fact that all subjects studied here were nondemented and yet without clinically relevant Aβ uptake. Furthermore, the increases in functional connectivity were independent of any structural alterations since no comparable relationships were observed for Aβ uptake with any regional gray or white matter changes. It therefore seems that changes in functional connectivity occur before structural deteriorations in the early stages of pathology of AD.

Increased functional connectivity is usually related to better cognitive performance ([@bhz020C25]; [@bhz020C79]). Accordingly, the higher dynamic functional connectivity, which were correlated with early Aβ accumulation, were also associated with better global cognitive function (i.e., higher MMSE scores). The trimodal relationships between amyloid uptake (in the early Aβ region), functional connectivity and cognitive performance could reflect a potential compensatory mechanism, a commonly observed manifestation of cognitive reserve in early stages of dementia ([@bhz020C12]; [@bhz020C68]; [@bhz020C2]; [@bhz020C48]), where enhanced brain function compensates for amyloid-induced neuronal damage and structural deterioration later in the disease. The phenomenon has been observed across a wide range of imaging modalities, including neuronal activation ([@bhz020C64]; [@bhz020C19]), functional ([@bhz020C53]; [@bhz020C61]), and metabolic connectivity ([@bhz020C56]) and even for gray matter volume ([@bhz020C70]). Hence, there is great amount of work suggesting that subjects with better cognitive performance also exhibit an increased ability to recruit neuronal networks in order to counterbalance the increased amyloid burden. In line with this, our data might indicate that the increased functional connectivity is more common in individuals with a greater cognitive reserve. As the main novel finding, we demonstrate that these mechanisms are already at play when global Aβ uptake is still within the normal range, thereby possibly capturing the earliest manifestations of cognitive reserve as a response to emerging pathological processes. The importance to assess early Aβ accumulation has also recently been confirmed, as this can be detected in cognitively normal subjects ([@bhz020C23]; [@bhz020C24]; [@bhz020C26]), it is associated with increased tau deposition ([@bhz020C41]) and with subsequent memory decline ([@bhz020C20]; [@bhz020C40]).

On the other hand, the recruitment of additional networks could also imply that these subjects are more affected by AD pathology. The increased connectivity would then allow subjects in the early disease stages to tolerate a higher amount of amyloid deposition while maintaining high cognitive function ([@bhz020C68]) as it was also shown with the current findings. These compensatory mechanisms may however fail with further disease progression and when pathology overwhelms function. The view of initially high cognitive performance but rapid decrease afterwards is supported by several studies, particularly with respect to functional connectivity, suggesting an inverted U-shape of cognitive function. That is, functional connectivity of different brain networks has been shown to first increase with increasing yet normal brain amyloid accumulation while maintaining high cognitive function, but then again decreases as amyloid reaches abnormal levels ([@bhz020C16]; [@bhz020C9]; [@bhz020C53]; [@bhz020C60]). Hence, a key aspect of future research will be to identify the individual time point of this deterioration and to establish potentially preventive interventions.

Finally, we would like to add an alternative explanation, as increased connectivity may also reflect hyperintense synchronous activity, which in turn regulates Aβ accumulation ([@bhz020C5]; [@bhz020C50]). Longitudinal studies are however required to clarify the exact underlying causes of the observed alterations.

The strength of the present study is the collection of a wide variety of imaging and cognitive measures in a large sample of Aβ-negative nondemented individuals. A limitation is that 6 min of resting state fMRI is on the lower boundary to assess dynamic functional connectivity (but similar ([@bhz020C35]) or even shorter durations have been used previously ([@bhz020C1]; [@bhz020C8]; [@bhz020C76])). Hence, it is possible that the scan time was simply too short since not all subjects experienced every state. However, there was no difference for subjects who did or did not exhibit state 1 regarding amyloid SUVR or cognitive test scores. Furthermore, it has been shown that 60 s windows ([@bhz020C29]) (or even 30 s ([@bhz020C8])) are sufficiently long to evaluate dynamic connectivity, which yields up to 150 states per subject and on average 25 occurrences of each state.

Although the MMSE is not a particularly sensitive test in normal subjects, it is highly reliable and represents a standard assessment to test cognitive function. As such it is also part of a test battery that is widely used in preclinical AD including clinically normal elderly individuals ([@bhz020C17]).

Conclusion {#bhz020s17}
==========

We demonstrate that amyloid-related effects on dynamic functional connectivity already occur at the earliest stage of the disease, namely, in nondemented elderly subjects without clinically relevant global amyloid deposition and these effects are independent of structural alterations in gray and white matter. The enhanced functional connectivity may represent a compensatory mechanism to maintain cognitive function despite increasing amyloid pathology. Future research is needed to examine whether changes in functional connectivity may be clinically relevant to predict individual decline in cognitive function and disease progression.
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